nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—Levonordefrin—Phenylpropanolamine—obesity	0.229	1	CrCrCtD
Salbutamol—ADRB1—obesity	0.176	0.543	CbGaD
Salbutamol—ADRB2—obesity	0.148	0.457	CbGaD
Salbutamol—ADRB2—Phenylpropanolamine—obesity	0.102	0.357	CbGbCtD
Salbutamol—ADRB1—Phenylpropanolamine—obesity	0.101	0.351	CbGbCtD
Salbutamol—CYP3A4—Sibutramine—obesity	0.0226	0.0787	CbGbCtD
Salbutamol—CYP3A4—Benzphetamine—obesity	0.0171	0.0596	CbGbCtD
Salbutamol—CYP3A4—Bupropion—obesity	0.0145	0.0507	CbGbCtD
Salbutamol—CYP3A4—Orlistat—obesity	0.0119	0.0413	CbGbCtD
Salbutamol—CYP3A4—Cimetidine—obesity	0.0107	0.0372	CbGbCtD
Salbutamol—CYP3A4—Topiramate—obesity	0.00699	0.0244	CbGbCtD
Salbutamol—Isoprenaline—PIK3R1—obesity	0.000354	0.0835	CrCbGaD
Salbutamol—Nadolol—ADRB3—obesity	0.000265	0.0625	CrCbGaD
Salbutamol—Clenbuterol—ADRB3—obesity	0.000256	0.0603	CrCbGaD
Salbutamol—Bupranolol—ADRB3—obesity	0.000253	0.0597	CrCbGaD
Salbutamol—Pirbuterol—ADRB1—obesity	0.000177	0.0419	CrCbGaD
Salbutamol—Levobunolol—ADRB1—obesity	0.000158	0.0373	CrCbGaD
Salbutamol—Pirbuterol—ADRB2—obesity	0.000149	0.0352	CrCbGaD
Salbutamol—Terbutaline—BCHE—obesity	0.000142	0.0334	CrCbGaD
Salbutamol—Isoetarine—ADRB1—obesity	0.000139	0.0328	CrCbGaD
Salbutamol—Carteolol—ADRB1—obesity	0.000134	0.0317	CrCbGaD
Salbutamol—Levobunolol—ADRB2—obesity	0.000133	0.0314	CrCbGaD
Salbutamol—Isoprenaline—ADRB3—obesity	0.000128	0.0302	CrCbGaD
Salbutamol—Terbutaline—ADRB2—obesity	0.000122	0.0287	CrCbGaD
Salbutamol—Nadolol—ADRB1—obesity	0.00012	0.0283	CrCbGaD
Salbutamol—Norepinephrine—ADRB3—obesity	0.000118	0.0279	CrCbGaD
Salbutamol—Isoetarine—ADRB2—obesity	0.000117	0.0276	CrCbGaD
Salbutamol—Clenbuterol—ADRB1—obesity	0.000116	0.0273	CrCbGaD
Salbutamol—Bupranolol—ADRB1—obesity	0.000114	0.027	CrCbGaD
Salbutamol—Carteolol—ADRB2—obesity	0.000113	0.0267	CrCbGaD
Salbutamol—Clenbuterol—TNF—obesity	0.00011	0.0259	CrCbGaD
Salbutamol—Epinephrine—ADRB3—obesity	0.000107	0.0253	CrCbGaD
Salbutamol—Ill-defined disorder—Sibutramine—obesity	0.000106	0.000956	CcSEcCtD
Salbutamol—Agitation—Sibutramine—obesity	0.000105	0.000947	CcSEcCtD
Salbutamol—Angioedema—Sibutramine—obesity	0.000104	0.000941	CcSEcCtD
Salbutamol—Palpitations—Orlistat—obesity	0.000104	0.000941	CcSEcCtD
Salbutamol—Salmeterol—ADRB2—obesity	0.000103	0.0244	CrCbGaD
Salbutamol—Angiopathy—Bupropion—obesity	0.000103	0.000936	CcSEcCtD
Salbutamol—Migraine—Topiramate—obesity	0.000103	0.000935	CcSEcCtD
Salbutamol—Affect lability—Topiramate—obesity	0.000103	0.000935	CcSEcCtD
Salbutamol—Nausea—Cimetidine—obesity	0.000103	0.000935	CcSEcCtD
Salbutamol—Immune system disorder—Bupropion—obesity	0.000103	0.000932	CcSEcCtD
Salbutamol—Mediastinal disorder—Bupropion—obesity	0.000103	0.00093	CcSEcCtD
Salbutamol—Malaise—Sibutramine—obesity	0.000103	0.000929	CcSEcCtD
Salbutamol—Cough—Orlistat—obesity	0.000103	0.000929	CcSEcCtD
Salbutamol—Chills—Bupropion—obesity	0.000102	0.000926	CcSEcCtD
Salbutamol—Vertigo—Sibutramine—obesity	0.000102	0.000925	CcSEcCtD
Salbutamol—Syncope—Sibutramine—obesity	0.000102	0.000924	CcSEcCtD
Salbutamol—Arrhythmia—Bupropion—obesity	0.000102	0.000921	CcSEcCtD
Salbutamol—Nadolol—ADRB2—obesity	0.000101	0.0238	CrCbGaD
Salbutamol—Palpitations—Sibutramine—obesity	0.0001	0.00091	CcSEcCtD
Salbutamol—Irritability—Topiramate—obesity	0.0001	0.000907	CcSEcCtD
Salbutamol—Myalgia—Orlistat—obesity	0.0001	0.000906	CcSEcCtD
Salbutamol—Chest pain—Orlistat—obesity	0.0001	0.000906	CcSEcCtD
Salbutamol—Loss of consciousness—Sibutramine—obesity	0.0001	0.000905	CcSEcCtD
Salbutamol—Mental disorder—Bupropion—obesity	9.98e-05	0.000904	CcSEcCtD
Salbutamol—Anxiety—Orlistat—obesity	9.97e-05	0.000903	CcSEcCtD
Salbutamol—Mood swings—Topiramate—obesity	9.94e-05	0.0009	CcSEcCtD
Salbutamol—Cough—Sibutramine—obesity	9.92e-05	0.000899	CcSEcCtD
Salbutamol—Malnutrition—Bupropion—obesity	9.91e-05	0.000898	CcSEcCtD
Salbutamol—Discomfort—Orlistat—obesity	9.88e-05	0.000895	CcSEcCtD
Salbutamol—Ataxia—Topiramate—obesity	9.86e-05	0.000893	CcSEcCtD
Salbutamol—Hypertension—Sibutramine—obesity	9.82e-05	0.000889	CcSEcCtD
Salbutamol—Dry mouth—Orlistat—obesity	9.78e-05	0.000886	CcSEcCtD
Salbutamol—Flatulence—Bupropion—obesity	9.77e-05	0.000885	CcSEcCtD
Salbutamol—Tension—Bupropion—obesity	9.73e-05	0.000881	CcSEcCtD
Salbutamol—Clenbuterol—ADRB2—obesity	9.73e-05	0.0229	CrCbGaD
Salbutamol—Dysgeusia—Bupropion—obesity	9.71e-05	0.000879	CcSEcCtD
Salbutamol—Myalgia—Sibutramine—obesity	9.68e-05	0.000877	CcSEcCtD
Salbutamol—Chest pain—Sibutramine—obesity	9.68e-05	0.000877	CcSEcCtD
Salbutamol—Arthralgia—Sibutramine—obesity	9.68e-05	0.000877	CcSEcCtD
Salbutamol—Anxiety—Sibutramine—obesity	9.65e-05	0.000874	CcSEcCtD
Salbutamol—Nervousness—Bupropion—obesity	9.63e-05	0.000872	CcSEcCtD
Salbutamol—Bupranolol—ADRB2—obesity	9.62e-05	0.0227	CrCbGaD
Salbutamol—Oedema—Orlistat—obesity	9.59e-05	0.000869	CcSEcCtD
Salbutamol—Anaphylactic shock—Orlistat—obesity	9.59e-05	0.000869	CcSEcCtD
Salbutamol—Back pain—Bupropion—obesity	9.59e-05	0.000869	CcSEcCtD
Salbutamol—Abdominal pain upper—Topiramate—obesity	9.58e-05	0.000868	CcSEcCtD
Salbutamol—Discomfort—Sibutramine—obesity	9.57e-05	0.000866	CcSEcCtD
Salbutamol—Hypokalaemia—Topiramate—obesity	9.55e-05	0.000865	CcSEcCtD
Salbutamol—Muscle spasms—Bupropion—obesity	9.53e-05	0.000863	CcSEcCtD
Salbutamol—Infection—Orlistat—obesity	9.53e-05	0.000863	CcSEcCtD
Salbutamol—Dry mouth—Sibutramine—obesity	9.47e-05	0.000858	CcSEcCtD
Salbutamol—Nervous system disorder—Orlistat—obesity	9.4e-05	0.000852	CcSEcCtD
Salbutamol—Nasopharyngitis—Topiramate—obesity	9.38e-05	0.000849	CcSEcCtD
Salbutamol—Skin disorder—Orlistat—obesity	9.32e-05	0.000844	CcSEcCtD
Salbutamol—Tremor—Bupropion—obesity	9.29e-05	0.000841	CcSEcCtD
Salbutamol—Anaphylactic shock—Sibutramine—obesity	9.28e-05	0.000841	CcSEcCtD
Salbutamol—Oedema—Sibutramine—obesity	9.28e-05	0.000841	CcSEcCtD
Salbutamol—Hyperhidrosis—Orlistat—obesity	9.27e-05	0.00084	CcSEcCtD
Salbutamol—Infection—Sibutramine—obesity	9.22e-05	0.000835	CcSEcCtD
Salbutamol—Ill-defined disorder—Bupropion—obesity	9.2e-05	0.000833	CcSEcCtD
Salbutamol—Shock—Sibutramine—obesity	9.13e-05	0.000827	CcSEcCtD
Salbutamol—Abdominal distension—Topiramate—obesity	9.13e-05	0.000827	CcSEcCtD
Salbutamol—Agitation—Bupropion—obesity	9.11e-05	0.000825	CcSEcCtD
Salbutamol—Asthma—Topiramate—obesity	9.07e-05	0.000821	CcSEcCtD
Salbutamol—Angioedema—Bupropion—obesity	9.06e-05	0.00082	CcSEcCtD
Salbutamol—Tachycardia—Sibutramine—obesity	9.06e-05	0.00082	CcSEcCtD
Salbutamol—Skin disorder—Sibutramine—obesity	9.02e-05	0.000817	CcSEcCtD
Salbutamol—Hyperhidrosis—Sibutramine—obesity	8.97e-05	0.000813	CcSEcCtD
Salbutamol—Malaise—Bupropion—obesity	8.94e-05	0.00081	CcSEcCtD
Salbutamol—Vertigo—Bupropion—obesity	8.91e-05	0.000807	CcSEcCtD
Salbutamol—Syncope—Bupropion—obesity	8.89e-05	0.000805	CcSEcCtD
Salbutamol—Anorexia—Sibutramine—obesity	8.85e-05	0.000801	CcSEcCtD
Salbutamol—Sweating increased—Topiramate—obesity	8.83e-05	0.0008	CcSEcCtD
Salbutamol—Angina pectoris—Topiramate—obesity	8.83e-05	0.0008	CcSEcCtD
Salbutamol—Palpitations—Bupropion—obesity	8.76e-05	0.000794	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Orlistat—obesity	8.74e-05	0.000791	CcSEcCtD
Salbutamol—Bronchitis—Topiramate—obesity	8.72e-05	0.00079	CcSEcCtD
Salbutamol—Loss of consciousness—Bupropion—obesity	8.71e-05	0.000789	CcSEcCtD
Salbutamol—Insomnia—Orlistat—obesity	8.67e-05	0.000786	CcSEcCtD
Salbutamol—Hypotension—Sibutramine—obesity	8.67e-05	0.000785	CcSEcCtD
Salbutamol—Cough—Bupropion—obesity	8.65e-05	0.000784	CcSEcCtD
Salbutamol—Paraesthesia—Orlistat—obesity	8.61e-05	0.00078	CcSEcCtD
Salbutamol—Hypertension—Bupropion—obesity	8.56e-05	0.000775	CcSEcCtD
Salbutamol—Dysuria—Topiramate—obesity	8.48e-05	0.000768	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Sibutramine—obesity	8.46e-05	0.000766	CcSEcCtD
Salbutamol—Dyspepsia—Orlistat—obesity	8.44e-05	0.000765	CcSEcCtD
Salbutamol—Arthralgia—Bupropion—obesity	8.44e-05	0.000764	CcSEcCtD
Salbutamol—Chest pain—Bupropion—obesity	8.44e-05	0.000764	CcSEcCtD
Salbutamol—Myalgia—Bupropion—obesity	8.44e-05	0.000764	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Topiramate—obesity	8.43e-05	0.000763	CcSEcCtD
Salbutamol—Anxiety—Bupropion—obesity	8.41e-05	0.000762	CcSEcCtD
Salbutamol—Insomnia—Sibutramine—obesity	8.39e-05	0.00076	CcSEcCtD
Salbutamol—Discomfort—Bupropion—obesity	8.34e-05	0.000755	CcSEcCtD
Salbutamol—Decreased appetite—Orlistat—obesity	8.34e-05	0.000755	CcSEcCtD
Salbutamol—Paraesthesia—Sibutramine—obesity	8.33e-05	0.000755	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Orlistat—obesity	8.28e-05	0.00075	CcSEcCtD
Salbutamol—Dyspnoea—Sibutramine—obesity	8.27e-05	0.000749	CcSEcCtD
Salbutamol—Fatigue—Orlistat—obesity	8.27e-05	0.000749	CcSEcCtD
Salbutamol—Dry mouth—Bupropion—obesity	8.25e-05	0.000748	CcSEcCtD
Salbutamol—Somnolence—Sibutramine—obesity	8.25e-05	0.000747	CcSEcCtD
Salbutamol—Pain—Orlistat—obesity	8.2e-05	0.000743	CcSEcCtD
Salbutamol—Hyperglycaemia—Topiramate—obesity	8.18e-05	0.000741	CcSEcCtD
Salbutamol—Dyspepsia—Sibutramine—obesity	8.17e-05	0.00074	CcSEcCtD
Salbutamol—Anaphylactic shock—Bupropion—obesity	8.09e-05	0.000733	CcSEcCtD
Salbutamol—Oedema—Bupropion—obesity	8.09e-05	0.000733	CcSEcCtD
Salbutamol—Decreased appetite—Sibutramine—obesity	8.07e-05	0.000731	CcSEcCtD
Salbutamol—Infection—Bupropion—obesity	8.04e-05	0.000728	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Sibutramine—obesity	8.01e-05	0.000726	CcSEcCtD
Salbutamol—Shock—Bupropion—obesity	7.96e-05	0.000721	CcSEcCtD
Salbutamol—Constipation—Sibutramine—obesity	7.94e-05	0.000719	CcSEcCtD
Salbutamol—Pain—Sibutramine—obesity	7.94e-05	0.000719	CcSEcCtD
Salbutamol—Nervous system disorder—Bupropion—obesity	7.94e-05	0.000719	CcSEcCtD
Salbutamol—Neuropathy peripheral—Topiramate—obesity	7.92e-05	0.000718	CcSEcCtD
Salbutamol—Feeling abnormal—Orlistat—obesity	7.9e-05	0.000716	CcSEcCtD
Salbutamol—Tachycardia—Bupropion—obesity	7.9e-05	0.000715	CcSEcCtD
Salbutamol—Stomatitis—Topiramate—obesity	7.88e-05	0.000714	CcSEcCtD
Salbutamol—Skin disorder—Bupropion—obesity	7.86e-05	0.000712	CcSEcCtD
Salbutamol—Urinary tract infection—Topiramate—obesity	7.86e-05	0.000712	CcSEcCtD
Salbutamol—Conjunctivitis—Topiramate—obesity	7.86e-05	0.000712	CcSEcCtD
Salbutamol—Gastrointestinal pain—Orlistat—obesity	7.84e-05	0.00071	CcSEcCtD
Salbutamol—Hyperhidrosis—Bupropion—obesity	7.82e-05	0.000708	CcSEcCtD
Salbutamol—Anorexia—Bupropion—obesity	7.71e-05	0.000699	CcSEcCtD
Salbutamol—Haematuria—Topiramate—obesity	7.71e-05	0.000698	CcSEcCtD
Salbutamol—Feeling abnormal—Sibutramine—obesity	7.65e-05	0.000693	CcSEcCtD
Salbutamol—Epistaxis—Topiramate—obesity	7.62e-05	0.00069	CcSEcCtD
Salbutamol—Urticaria—Orlistat—obesity	7.62e-05	0.00069	CcSEcCtD
Salbutamol—Gastrointestinal pain—Sibutramine—obesity	7.59e-05	0.000687	CcSEcCtD
Salbutamol—Sinusitis—Topiramate—obesity	7.58e-05	0.000687	CcSEcCtD
Salbutamol—Body temperature increased—Orlistat—obesity	7.58e-05	0.000687	CcSEcCtD
Salbutamol—Abdominal pain—Orlistat—obesity	7.58e-05	0.000687	CcSEcCtD
Salbutamol—Hypotension—Bupropion—obesity	7.56e-05	0.000685	CcSEcCtD
Salbutamol—Urticaria—Sibutramine—obesity	7.37e-05	0.000668	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Bupropion—obesity	7.37e-05	0.000668	CcSEcCtD
Salbutamol—Body temperature increased—Sibutramine—obesity	7.34e-05	0.000665	CcSEcCtD
Salbutamol—Abdominal pain—Sibutramine—obesity	7.34e-05	0.000665	CcSEcCtD
Salbutamol—Insomnia—Bupropion—obesity	7.32e-05	0.000663	CcSEcCtD
Salbutamol—Haemoglobin—Topiramate—obesity	7.29e-05	0.000661	CcSEcCtD
Salbutamol—Rhinitis—Topiramate—obesity	7.27e-05	0.000659	CcSEcCtD
Salbutamol—Paraesthesia—Bupropion—obesity	7.27e-05	0.000658	CcSEcCtD
Salbutamol—Haemorrhage—Topiramate—obesity	7.26e-05	0.000657	CcSEcCtD
Salbutamol—Hypoaesthesia—Topiramate—obesity	7.22e-05	0.000654	CcSEcCtD
Salbutamol—Dyspnoea—Bupropion—obesity	7.21e-05	0.000653	CcSEcCtD
Salbutamol—Pharyngitis—Topiramate—obesity	7.2e-05	0.000652	CcSEcCtD
Salbutamol—Somnolence—Bupropion—obesity	7.19e-05	0.000651	CcSEcCtD
Salbutamol—Urinary tract disorder—Topiramate—obesity	7.17e-05	0.000649	CcSEcCtD
Salbutamol—Connective tissue disorder—Topiramate—obesity	7.13e-05	0.000646	CcSEcCtD
Salbutamol—Dyspepsia—Bupropion—obesity	7.12e-05	0.000645	CcSEcCtD
Salbutamol—Urethral disorder—Topiramate—obesity	7.11e-05	0.000644	CcSEcCtD
Salbutamol—Hypersensitivity—Orlistat—obesity	7.07e-05	0.00064	CcSEcCtD
Salbutamol—Norepinephrine—SLC22A1—obesity	7.06e-05	0.0166	CrCbGaD
Salbutamol—Decreased appetite—Bupropion—obesity	7.03e-05	0.000637	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Bupropion—obesity	6.99e-05	0.000633	CcSEcCtD
Salbutamol—Fatigue—Bupropion—obesity	6.98e-05	0.000632	CcSEcCtD
Salbutamol—Constipation—Bupropion—obesity	6.92e-05	0.000627	CcSEcCtD
Salbutamol—Pain—Bupropion—obesity	6.92e-05	0.000627	CcSEcCtD
Salbutamol—Asthenia—Orlistat—obesity	6.88e-05	0.000623	CcSEcCtD
Salbutamol—Hypersensitivity—Sibutramine—obesity	6.84e-05	0.000619	CcSEcCtD
Salbutamol—Pruritus—Orlistat—obesity	6.79e-05	0.000615	CcSEcCtD
Salbutamol—Tinnitus—Topiramate—obesity	6.77e-05	0.000613	CcSEcCtD
Salbutamol—Cardiac disorder—Topiramate—obesity	6.73e-05	0.00061	CcSEcCtD
Salbutamol—Flushing—Topiramate—obesity	6.73e-05	0.00061	CcSEcCtD
Salbutamol—Feeling abnormal—Bupropion—obesity	6.67e-05	0.000604	CcSEcCtD
Salbutamol—Asthenia—Sibutramine—obesity	6.66e-05	0.000603	CcSEcCtD
Salbutamol—Gastrointestinal pain—Bupropion—obesity	6.62e-05	0.000599	CcSEcCtD
Salbutamol—Angiopathy—Topiramate—obesity	6.58e-05	0.000596	CcSEcCtD
Salbutamol—Pruritus—Sibutramine—obesity	6.57e-05	0.000595	CcSEcCtD
Salbutamol—Diarrhoea—Orlistat—obesity	6.56e-05	0.000594	CcSEcCtD
Salbutamol—Immune system disorder—Topiramate—obesity	6.55e-05	0.000594	CcSEcCtD
Salbutamol—Mediastinal disorder—Topiramate—obesity	6.54e-05	0.000592	CcSEcCtD
Salbutamol—Chills—Topiramate—obesity	6.51e-05	0.00059	CcSEcCtD
Salbutamol—Urticaria—Bupropion—obesity	6.43e-05	0.000582	CcSEcCtD
Salbutamol—Epinephrine—SLC22A1—obesity	6.4e-05	0.0151	CrCbGaD
Salbutamol—Body temperature increased—Bupropion—obesity	6.4e-05	0.000579	CcSEcCtD
Salbutamol—Abdominal pain—Bupropion—obesity	6.4e-05	0.000579	CcSEcCtD
Salbutamol—Mental disorder—Topiramate—obesity	6.36e-05	0.000576	CcSEcCtD
Salbutamol—Diarrhoea—Sibutramine—obesity	6.35e-05	0.000575	CcSEcCtD
Salbutamol—Dizziness—Orlistat—obesity	6.34e-05	0.000574	CcSEcCtD
Salbutamol—Malnutrition—Topiramate—obesity	6.32e-05	0.000572	CcSEcCtD
Salbutamol—Flatulence—Topiramate—obesity	6.22e-05	0.000564	CcSEcCtD
Salbutamol—Tension—Topiramate—obesity	6.2e-05	0.000561	CcSEcCtD
Salbutamol—Dysgeusia—Topiramate—obesity	6.19e-05	0.00056	CcSEcCtD
Salbutamol—Dizziness—Sibutramine—obesity	6.14e-05	0.000556	CcSEcCtD
Salbutamol—Nervousness—Topiramate—obesity	6.13e-05	0.000556	CcSEcCtD
Salbutamol—Back pain—Topiramate—obesity	6.11e-05	0.000553	CcSEcCtD
Salbutamol—Vomiting—Orlistat—obesity	6.1e-05	0.000552	CcSEcCtD
Salbutamol—Muscle spasms—Topiramate—obesity	6.07e-05	0.00055	CcSEcCtD
Salbutamol—Rash—Orlistat—obesity	6.05e-05	0.000548	CcSEcCtD
Salbutamol—Dermatitis—Orlistat—obesity	6.04e-05	0.000547	CcSEcCtD
Salbutamol—Headache—Orlistat—obesity	6.01e-05	0.000544	CcSEcCtD
Salbutamol—Hypersensitivity—Bupropion—obesity	5.96e-05	0.00054	CcSEcCtD
Salbutamol—Tremor—Topiramate—obesity	5.92e-05	0.000536	CcSEcCtD
Salbutamol—Vomiting—Sibutramine—obesity	5.9e-05	0.000534	CcSEcCtD
Salbutamol—Ill-defined disorder—Topiramate—obesity	5.86e-05	0.000531	CcSEcCtD
Salbutamol—Rash—Sibutramine—obesity	5.85e-05	0.00053	CcSEcCtD
Salbutamol—Dermatitis—Sibutramine—obesity	5.85e-05	0.00053	CcSEcCtD
Salbutamol—Headache—Sibutramine—obesity	5.81e-05	0.000527	CcSEcCtD
Salbutamol—Asthenia—Bupropion—obesity	5.81e-05	0.000526	CcSEcCtD
Salbutamol—Agitation—Topiramate—obesity	5.8e-05	0.000526	CcSEcCtD
Salbutamol—Isoprenaline—ADRB1—obesity	5.78e-05	0.0136	CrCbGaD
Salbutamol—Pruritus—Bupropion—obesity	5.72e-05	0.000518	CcSEcCtD
Salbutamol—Nausea—Orlistat—obesity	5.7e-05	0.000516	CcSEcCtD
Salbutamol—Malaise—Topiramate—obesity	5.7e-05	0.000516	CcSEcCtD
Salbutamol—Vertigo—Topiramate—obesity	5.67e-05	0.000514	CcSEcCtD
Salbutamol—Syncope—Topiramate—obesity	5.66e-05	0.000513	CcSEcCtD
Salbutamol—Palpitations—Topiramate—obesity	5.58e-05	0.000506	CcSEcCtD
Salbutamol—Loss of consciousness—Topiramate—obesity	5.55e-05	0.000503	CcSEcCtD
Salbutamol—Diarrhoea—Bupropion—obesity	5.54e-05	0.000501	CcSEcCtD
Salbutamol—Nausea—Sibutramine—obesity	5.51e-05	0.000499	CcSEcCtD
Salbutamol—Cough—Topiramate—obesity	5.51e-05	0.000499	CcSEcCtD
Salbutamol—Hypertension—Topiramate—obesity	5.45e-05	0.000494	CcSEcCtD
Salbutamol—Myalgia—Topiramate—obesity	5.38e-05	0.000487	CcSEcCtD
Salbutamol—Chest pain—Topiramate—obesity	5.38e-05	0.000487	CcSEcCtD
Salbutamol—Arthralgia—Topiramate—obesity	5.38e-05	0.000487	CcSEcCtD
Salbutamol—Anxiety—Topiramate—obesity	5.36e-05	0.000485	CcSEcCtD
Salbutamol—Norepinephrine—ADRB1—obesity	5.35e-05	0.0126	CrCbGaD
Salbutamol—Dizziness—Bupropion—obesity	5.35e-05	0.000485	CcSEcCtD
Salbutamol—Discomfort—Topiramate—obesity	5.31e-05	0.000481	CcSEcCtD
Salbutamol—Dry mouth—Topiramate—obesity	5.26e-05	0.000476	CcSEcCtD
Salbutamol—Oedema—Topiramate—obesity	5.16e-05	0.000467	CcSEcCtD
Salbutamol—Vomiting—Bupropion—obesity	5.14e-05	0.000466	CcSEcCtD
Salbutamol—Infection—Topiramate—obesity	5.12e-05	0.000464	CcSEcCtD
Salbutamol—Rash—Bupropion—obesity	5.1e-05	0.000462	CcSEcCtD
Salbutamol—Dermatitis—Bupropion—obesity	5.1e-05	0.000462	CcSEcCtD
Salbutamol—Shock—Topiramate—obesity	5.07e-05	0.000459	CcSEcCtD
Salbutamol—Headache—Bupropion—obesity	5.07e-05	0.000459	CcSEcCtD
Salbutamol—Nervous system disorder—Topiramate—obesity	5.06e-05	0.000458	CcSEcCtD
Salbutamol—Tachycardia—Topiramate—obesity	5.03e-05	0.000456	CcSEcCtD
Salbutamol—Skin disorder—Topiramate—obesity	5.01e-05	0.000454	CcSEcCtD
Salbutamol—Hyperhidrosis—Topiramate—obesity	4.98e-05	0.000451	CcSEcCtD
Salbutamol—Anorexia—Topiramate—obesity	4.91e-05	0.000445	CcSEcCtD
Salbutamol—Isoprenaline—ADRB2—obesity	4.86e-05	0.0115	CrCbGaD
Salbutamol—Epinephrine—ADRB1—obesity	4.86e-05	0.0115	CrCbGaD
Salbutamol—Hypotension—Topiramate—obesity	4.82e-05	0.000436	CcSEcCtD
Salbutamol—Nausea—Bupropion—obesity	4.81e-05	0.000435	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Topiramate—obesity	4.7e-05	0.000425	CcSEcCtD
Salbutamol—Insomnia—Topiramate—obesity	4.66e-05	0.000422	CcSEcCtD
Salbutamol—Paraesthesia—Topiramate—obesity	4.63e-05	0.000419	CcSEcCtD
Salbutamol—Epinephrine—TNF—obesity	4.61e-05	0.0109	CrCbGaD
Salbutamol—Dyspnoea—Topiramate—obesity	4.6e-05	0.000416	CcSEcCtD
Salbutamol—Somnolence—Topiramate—obesity	4.58e-05	0.000415	CcSEcCtD
Salbutamol—Dyspepsia—Topiramate—obesity	4.54e-05	0.000411	CcSEcCtD
Salbutamol—Norepinephrine—ADRB2—obesity	4.5e-05	0.0106	CrCbGaD
Salbutamol—Decreased appetite—Topiramate—obesity	4.48e-05	0.000406	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Topiramate—obesity	4.45e-05	0.000403	CcSEcCtD
Salbutamol—Fatigue—Topiramate—obesity	4.44e-05	0.000403	CcSEcCtD
Salbutamol—Pain—Topiramate—obesity	4.41e-05	0.000399	CcSEcCtD
Salbutamol—Constipation—Topiramate—obesity	4.41e-05	0.000399	CcSEcCtD
Salbutamol—Feeling abnormal—Topiramate—obesity	4.25e-05	0.000385	CcSEcCtD
Salbutamol—Gastrointestinal pain—Topiramate—obesity	4.22e-05	0.000382	CcSEcCtD
Salbutamol—Urticaria—Topiramate—obesity	4.1e-05	0.000371	CcSEcCtD
Salbutamol—Epinephrine—ADRB2—obesity	4.09e-05	0.00964	CrCbGaD
Salbutamol—Body temperature increased—Topiramate—obesity	4.08e-05	0.000369	CcSEcCtD
Salbutamol—Abdominal pain—Topiramate—obesity	4.08e-05	0.000369	CcSEcCtD
Salbutamol—Norepinephrine—DRD2—obesity	4.07e-05	0.00959	CrCbGaD
Salbutamol—Hypersensitivity—Topiramate—obesity	3.8e-05	0.000344	CcSEcCtD
Salbutamol—Asthenia—Topiramate—obesity	3.7e-05	0.000335	CcSEcCtD
Salbutamol—Pruritus—Topiramate—obesity	3.65e-05	0.00033	CcSEcCtD
Salbutamol—Diarrhoea—Topiramate—obesity	3.53e-05	0.000319	CcSEcCtD
Salbutamol—Dizziness—Topiramate—obesity	3.41e-05	0.000309	CcSEcCtD
Salbutamol—Vomiting—Topiramate—obesity	3.28e-05	0.000297	CcSEcCtD
Salbutamol—Rash—Topiramate—obesity	3.25e-05	0.000294	CcSEcCtD
Salbutamol—Dermatitis—Topiramate—obesity	3.25e-05	0.000294	CcSEcCtD
Salbutamol—Headache—Topiramate—obesity	3.23e-05	0.000292	CcSEcCtD
Salbutamol—Nausea—Topiramate—obesity	3.06e-05	0.000277	CcSEcCtD
Salbutamol—CYP3A4—Metabolism—DGAT1—obesity	8.22e-06	0.000181	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—POMC—obesity	8.19e-06	0.00018	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—F2—obesity	8.16e-06	0.000179	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PRKCB—obesity	8.16e-06	0.000179	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TCF7L2—obesity	8.08e-06	0.000178	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CNR1—obesity	8.05e-06	0.000177	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—AKT2—obesity	8.04e-06	0.000177	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD2—obesity	8.03e-06	0.000176	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PIK3CG—obesity	7.98e-06	0.000176	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GCG—obesity	7.94e-06	0.000175	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PTPN1—obesity	7.94e-06	0.000175	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ACLY—obesity	7.91e-06	0.000174	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TCF7L2—obesity	7.91e-06	0.000174	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—AKT2—obesity	7.87e-06	0.000173	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD2—obesity	7.85e-06	0.000173	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PIK3CG—obesity	7.81e-06	0.000172	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GCG—obesity	7.77e-06	0.000171	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PTPN1—obesity	7.77e-06	0.000171	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PIK3CD—obesity	7.73e-06	0.00017	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ENPP1—obesity	7.64e-06	0.000168	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALOX12—obesity	7.64e-06	0.000168	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—POMC—obesity	7.6e-06	0.000167	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRL—obesity	7.58e-06	0.000167	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PIK3CD—obesity	7.56e-06	0.000166	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—STK11—obesity	7.47e-06	0.000164	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCL2—obesity	7.44e-06	0.000164	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—POMC—obesity	7.43e-06	0.000163	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRL—obesity	7.41e-06	0.000163	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HMGCS1—obesity	7.4e-06	0.000163	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PLG—obesity	7.39e-06	0.000162	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—RHOA—obesity	7.37e-06	0.000162	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—STK11—obesity	7.31e-06	0.000161	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—AKT2—obesity	7.3e-06	0.000161	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PIK3R1—obesity	7.3e-06	0.00016	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCL2—obesity	7.27e-06	0.00016	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PLG—obesity	7.22e-06	0.000159	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—RHOA—obesity	7.21e-06	0.000159	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FOXO3—obesity	7.21e-06	0.000159	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ADRB2—obesity	7.19e-06	0.000158	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PNPLA2—obesity	7.19e-06	0.000158	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLIN1—obesity	7.19e-06	0.000158	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PFKFB3—obesity	7.19e-06	0.000158	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ACADM—obesity	7.19e-06	0.000158	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SAT1—obesity	7.19e-06	0.000158	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ANGPTL4—obesity	7.19e-06	0.000158	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—AKT2—obesity	7.15e-06	0.000157	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PIK3R1—obesity	7.14e-06	0.000157	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SOCS1—obesity	7.08e-06	0.000156	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FOXO3—obesity	7.05e-06	0.000155	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PIK3CD—obesity	7.02e-06	0.000154	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SOCS3—obesity	6.99e-06	0.000154	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—OXCT1—obesity	6.99e-06	0.000154	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ACACB—obesity	6.99e-06	0.000154	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYTB—obesity	6.99e-06	0.000154	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SOCS1—obesity	6.93e-06	0.000152	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PIK3CD—obesity	6.87e-06	0.000151	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GNB3—obesity	6.85e-06	0.000151	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SOCS3—obesity	6.84e-06	0.00015	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PNLIP—obesity	6.81e-06	0.00015	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SRD5A1—obesity	6.81e-06	0.00015	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—TYK2—obesity	6.75e-06	0.000148	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PIK3CB—obesity	6.74e-06	0.000148	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IGF2—obesity	6.73e-06	0.000148	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GNB3—obesity	6.7e-06	0.000147	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—RHOA—obesity	6.7e-06	0.000147	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GNAS—obesity	6.67e-06	0.000147	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SDC3—obesity	6.65e-06	0.000146	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PIK3R1—obesity	6.63e-06	0.000146	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—TYK2—obesity	6.6e-06	0.000145	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PIK3CB—obesity	6.59e-06	0.000145	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IGF2—obesity	6.58e-06	0.000145	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—RHOA—obesity	6.55e-06	0.000144	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APOB—obesity	6.53e-06	0.000144	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GNAS—obesity	6.52e-06	0.000143	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—STS—obesity	6.5e-06	0.000143	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP26B1—obesity	6.5e-06	0.000143	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HK2—obesity	6.5e-06	0.000143	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PIK3R1—obesity	6.48e-06	0.000143	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APOB—obesity	6.39e-06	0.00014	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL5—obesity	6.38e-06	0.00014	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARD—obesity	6.36e-06	0.00014	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL5—obesity	6.24e-06	0.000137	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LPL—obesity	6.23e-06	0.000137	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC27A1—obesity	6.23e-06	0.000137	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FOXO1—obesity	6.19e-06	0.000136	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RPS6KB1—obesity	6.18e-06	0.000136	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PIK3CB—obesity	6.12e-06	0.000135	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—FABP4—obesity	6.11e-06	0.000134	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GLUL—obesity	6.11e-06	0.000134	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LPL—obesity	6.1e-06	0.000134	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FOXO1—obesity	6.05e-06	0.000133	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—RPS6KB1—obesity	6.04e-06	0.000133	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PIK3CB—obesity	5.98e-06	0.000132	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HSD11B1—obesity	5.79e-06	0.000127	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—UCP3—obesity	5.79e-06	0.000127	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—UCP2—obesity	5.79e-06	0.000127	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ECHS1—obesity	5.79e-06	0.000127	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRKCD—obesity	5.74e-06	0.000126	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADH1B—obesity	5.7e-06	0.000125	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2A—obesity	5.62e-06	0.000124	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRKCD—obesity	5.62e-06	0.000124	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—C3—obesity	5.61e-06	0.000123	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GPAM—obesity	5.61e-06	0.000123	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ACSL1—obesity	5.61e-06	0.000123	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARGC1B—obesity	5.61e-06	0.000123	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2A—obesity	5.5e-06	0.000121	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—C3—obesity	5.49e-06	0.000121	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PCK1—obesity	5.45e-06	0.00012	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HADH—obesity	5.45e-06	0.00012	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—FADS1—obesity	5.45e-06	0.00012	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IRS2—obesity	5.34e-06	0.000117	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AGT—obesity	5.33e-06	0.000117	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ACP5—obesity	5.3e-06	0.000117	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LEP—obesity	5.23e-06	0.000115	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APOE—obesity	5.23e-06	0.000115	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IRS2—obesity	5.22e-06	0.000115	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AGT—obesity	5.22e-06	0.000115	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CAV1—obesity	5.18e-06	0.000114	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APOA1—obesity	5.17e-06	0.000114	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—G6PD—obesity	5.16e-06	0.000114	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APOE—obesity	5.11e-06	0.000112	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LEP—obesity	5.11e-06	0.000112	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HK1—obesity	5.1e-06	0.000112	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SREBF2—obesity	5.1e-06	0.000112	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CAV1—obesity	5.06e-06	0.000111	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APOA1—obesity	5.05e-06	0.000111	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ESR1—obesity	4.99e-06	0.00011	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—F2—obesity	4.93e-06	0.000108	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRKCB—obesity	4.93e-06	0.000108	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LPA—obesity	4.93e-06	0.000108	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ESR1—obesity	4.88e-06	0.000107	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—BAD—obesity	4.87e-06	0.000107	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—F2—obesity	4.82e-06	0.000106	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRKCB—obesity	4.82e-06	0.000106	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LPIN1—obesity	4.82e-06	0.000106	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—BAD—obesity	4.76e-06	0.000105	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOA5—obesity	4.72e-06	0.000104	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PIK3CG—obesity	4.72e-06	0.000104	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IRS1—obesity	4.66e-06	0.000103	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PIK3CG—obesity	4.61e-06	0.000101	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IRS1—obesity	4.56e-06	0.0001	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC22A1—obesity	4.51e-06	9.91e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CLOCK—obesity	4.51e-06	9.91e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—POMC—obesity	4.49e-06	9.87e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—INS—obesity	4.46e-06	9.82e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL2—obesity	4.39e-06	9.66e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—POMC—obesity	4.39e-06	9.66e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SULT2A1—obesity	4.39e-06	9.66e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GLP1R—obesity	4.39e-06	9.66e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—INS—obesity	4.37e-06	9.6e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DPYD—obesity	4.32e-06	9.5e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IGF1—obesity	4.32e-06	9.5e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AKT2—obesity	4.31e-06	9.49e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL2—obesity	4.3e-06	9.45e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IGF1—obesity	4.22e-06	9.29e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AKT2—obesity	4.22e-06	9.28e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PRKAR2B—obesity	4.16e-06	9.14e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PIK3CD—obesity	4.15e-06	9.12e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DCN—obesity	4.13e-06	9.08e-05	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	4.11e-06	9.03e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SERPINE1—obesity	4.1e-06	9.02e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PIK3CD—obesity	4.06e-06	8.92e-05	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	4.02e-06	8.83e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CPT1A—obesity	4.02e-06	8.83e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SERPINE1—obesity	4.01e-06	8.82e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TYK2—obesity	3.99e-06	8.77e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RHOA—obesity	3.96e-06	8.7e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NAMPT—obesity	3.94e-06	8.66e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PIK3R1—obesity	3.91e-06	8.61e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NOS3—obesity	3.91e-06	8.61e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LIPC—obesity	3.91e-06	8.61e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GCK—obesity	3.91e-06	8.61e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TYK2—obesity	3.9e-06	8.58e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOC3—obesity	3.89e-06	8.55e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—RHOA—obesity	3.87e-06	8.51e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NOS3—obesity	3.83e-06	8.42e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PIK3R1—obesity	3.83e-06	8.42e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CETP—obesity	3.78e-06	8.3e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SDC1—obesity	3.73e-06	8.21e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PIK3CA—obesity	3.73e-06	8.2e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AKR1C3—obesity	3.67e-06	8.08e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PIK3CA—obesity	3.65e-06	8.02e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SCARB1—obesity	3.62e-06	7.95e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PIK3CB—obesity	3.61e-06	7.95e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MTOR—obesity	3.61e-06	7.95e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MTOR—obesity	3.53e-06	7.77e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PIK3CB—obesity	3.53e-06	7.77e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SREBF1—obesity	3.51e-06	7.72e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GOT2—obesity	3.41e-06	7.51e-05	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—AKT1—obesity	3.35e-06	7.38e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—FASN—obesity	3.34e-06	7.35e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—BCHE—obesity	3.33e-06	7.32e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL6—obesity	3.3e-06	7.26e-05	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—AKT1—obesity	3.28e-06	7.22e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL6—obesity	3.23e-06	7.1e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP2E1—obesity	3.21e-06	7.06e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NQO1—obesity	3.17e-06	6.98e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MMP9—obesity	3.14e-06	6.91e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MMP9—obesity	3.07e-06	6.76e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MAPK8—obesity	3.05e-06	6.72e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—AKT1—obesity	3.05e-06	6.7e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC2A4—obesity	3.04e-06	6.69e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GCG—obesity	3.04e-06	6.69e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYCS—obesity	3e-06	6.61e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MAPK8—obesity	2.99e-06	6.57e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—AKT1—obesity	2.98e-06	6.55e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GOT1—obesity	2.95e-06	6.48e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GGT1—obesity	2.95e-06	6.48e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NCOA1—obesity	2.9e-06	6.38e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—STK11—obesity	2.86e-06	6.29e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP19A1—obesity	2.86e-06	6.29e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—STAT3—obesity	2.79e-06	6.14e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—STAT3—obesity	2.73e-06	6.01e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—COMT—obesity	2.66e-06	5.85e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARGC1A—obesity	2.62e-06	5.77e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GNB3—obesity	2.62e-06	5.77e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HMOX1—obesity	2.61e-06	5.74e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MYC—obesity	2.59e-06	5.71e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TGFB1—obesity	2.59e-06	5.69e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GNAS—obesity	2.55e-06	5.62e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MYC—obesity	2.54e-06	5.58e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TGFB1—obesity	2.53e-06	5.57e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOB—obesity	2.5e-06	5.5e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LPL—obesity	2.39e-06	5.25e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GPX1—obesity	2.33e-06	5.12e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CD36—obesity	2.27e-06	4.99e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PIK3CA—obesity	2.2e-06	4.84e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PIK3CA—obesity	2.15e-06	4.74e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MTHFR—obesity	2.15e-06	4.73e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARA—obesity	2.11e-06	4.64e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AGT—obesity	2.04e-06	4.49e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOE—obesity	2e-06	4.4e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CAV1—obesity	1.98e-06	4.36e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOA1—obesity	1.98e-06	4.35e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL6—obesity	1.95e-06	4.29e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL6—obesity	1.91e-06	4.2e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3CG—obesity	1.81e-06	3.97e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AKT1—obesity	1.8e-06	3.96e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AKT1—obesity	1.76e-06	3.87e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARG—obesity	1.74e-06	3.83e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—POMC—obesity	1.72e-06	3.78e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—INS—obesity	1.71e-06	3.76e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3CD—obesity	1.59e-06	3.49e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALB—obesity	1.57e-06	3.45e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NOS3—obesity	1.5e-06	3.3e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3R1—obesity	1.5e-06	3.3e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3CB—obesity	1.38e-06	3.04e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGS2—obesity	1.37e-06	3.02e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3CA—obesity	8.44e-07	1.86e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AKT1—obesity	6.89e-07	1.52e-05	CbGpPWpGaD
